Long-term survival of a patient with liver metastases from clear cell gastric adenocarcinoma after multimodality treatment including interventional oncology techniques

case report

Vesna Jugovec (Avtor), Jernej Benedik (Avtor), Jera Jeruc (Avtor), Peter Popović (Avtor)

Povzetek

Background: Gastric cancer (GC) is the fourth most common cancer and the third leading cancer-related cause of death worldwide since most patients are diagnosed at an advanced stage. The majority of GCs are adenocarcinomas (ACs), and the poorly characterized clear cell AC represents a unique subgroup of GCs and is an independent marker of poor prognosis. Even though the prognosis for patients with advanced GC is poor we present a report of a patient with long-term survival despite having liver metastases from clear cell gastric AC. Case presentation: A 45-year-old male with clear cell gastric AC underwent subtotal gastrectomy and postoperative chemoradiation. Only a year and a half after his initial treatment the disease spread to his liver. He received two lines of chemotherapy treatment within the next two years before a right hepatectomy was suggested. Due to an initially insufficient future liver remnant (FLR), transarterial chemoembolization (TACE) and portal vein embolization (PVE) were performed, which made the surgical procedure possible. Shortly after a disease progression in the remaining liver was detected. In the following three years the patient was treated with a carefully planned combination of systemic therapy and different interventional oncology techniques including selective internal radiation therapy (SIRT) and TACE. And as illustrated, an attentive, patient-tailored, multimodality treatment approach can sometimes greatly benefit our patients as he had an overall survival of 88 months despite the poor prognosis of his disease. Conclusion: To the best of our knowledge, this report is the first to describe a patient with liver metastases from clear cell gastric AC treated with interventional oncology techniques (PVE, TACE, and SIRT) in combination with other locoregional and systemic therapies thereby presenting that these interventional oncology techniques can be successfully integrated into long-term management of non-conventional liver tumors.

Ključne besede

adenokarcinom želodca;preživetje;multimodalno zdravljenje;gastric adenocarcinoma;survival;multimodality treatment;

Podatki

Jezik:	Angleški jezik
Leto izida:	2022
Tipologija:	1.03 - Kratki znanstveni prispevek
Organizacija:	OI - Onkološki inštitut Ljubljana
Založnik:	BMC
UDK:	616.3
COBISS:	112216323
ISSN:	1471-230X
Št. ogledov:	7
Št. prenosov:	3
Ocena:	0 (0 glasov)
Metapodatki:

Ostali podatki

Sekundarni jezik:	Slovenski jezik
Sekundarne ključne besede:	adenokarcinom želodca;preživetje;multimodalno zdravljenje;
Komentar vira:	Nasl. z nasl. zaslona; Opis vira z dne 20. 6. 2022;
Strani:	str. 1-8
Letnik:	ǂVol. ǂ22
Zvezek:	ǂno. ǂ103
Čas izdaje:	2022
DOI:	10.1186/s12876-022-02150-y
ID:	16469501